Trial Profile
A safety and efficacy trial of fingolimod in clinical practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 31 Mar 2016 New trial record